Business | Economy, Finance & ASX Market News | The Sydney Morning Herald

We’re sorry, this feature is currently unavailable. We’re working to restore it. Please try again later.

Advertisement

Market movers

Loading
The competition watchdog said

ANZ to challenge ACCC knockback of $4.9b Suncorp deal

ANZ will appeal the ACCC’s rejection of what would have been the biggest transaction in Australian banking since Westpac’s 2008 takeover of St George.

  • by Millie Muroi
Loading
Loading
Loading

Currency

Loading

Copyright © 2023. Market data information displayed on The Sydney Morning Herald is sourced from Morningstar and ASX and is subject to their terms and conditions as set out in our terms of use. The Sydney Morning Herald does not accept any responsibility for the accuracy and/or completeness of such data or information.

Morningstar logoASX logo

Companies

US Food and Drug Administration issued a “complete response letter” to Mesoblast in October 2020, asking for more data on its treatment before it could be approved in the US market.

Mesoblast shares tank after US FDA delays stem cell approval again

The US regulator has again asked for more data on the stem cell treatment maker’s flagship product, which was blocked from approval in 2020 for the same reason.

  • by Emma Koehn and Jessica Yun
Gina Rinehart is locked in a court battle with the descendants of her father’s business over royalties from a mining tenement in Western Australia’s iron-rich Pilbara region.
Exclusive
Mining

Will Rio Tinto be dragged into the $1.22 billion Hancock case?

Descendants of the business partners of Gina Rinehart’s father want to claw back billions of dollars in iron ore royalties from her company Hancock Prospecting.

  • by Simon Johanson and Jesinta Burton
Advertisement

Opinion & Perspectives

NSW Treasury kicks off the new realism: Productivity won’t be speeding up

Economists don’t know as much about what causes productivity improvement as they ought to.

Ross Gittins
Ross Gittins

Economics Editor

The ‘financial heroin’ product that ASIC is trying to bust

Having a win represents a massive high. But if punters lose, withdrawal is financially painful.

Elizabeth Knight
Elizabeth Knight

Business columnist

The $2.8 trillion question: America is hunting for cash, but there’s a bit of a problem

The US is going to put trillions worth of new debt up for sale before the end of the year as it tries to rebuild its cash reserves. There is an issue, however.

Stephen Bartholomeusz
Stephen Bartholomeusz

Senior business columnist

Banking & finance

Advertisement

Entrepreneurship

Birchal CEO Matt Vitale with chief legal officer Kellie Morton and chair Adam Vise.

Beer, cannabis, hydrogen: Plenty of cash to splash on crowdfunding campaigns

Cost of living crisis be damned; economic downturns are precisely when equity crowdfunding tends to flourish, says Birchal boss Matt Vitale.

  • by Jessica Yun
Steve Leven, a former basketball player, is accused of faking his PhD from Columbia University.
Investigation
Start-ups

This athlete turned tech bro was chasing a start-up dream. Now he’s accused of faking a PhD

The start-up world is full of entrepreneurs like Steven Leven, striving for dreams that others see as implausible. But there are boundaries.

  • by Anthony Segaert and Nick Bonyhady

Popular in Business

Loading
Advertisement